

Calidi Biotherapeutics (NYSE: CLDI) surged 39.47% after hours Tuesday, following renewed investor interest in its innovative cancer treatment developments.
You can purchase shares of Mustang Bio (NASDAQ:MBIO) through any online brokerage.
Other companies in Mustang Bio’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Mustang Bio has a consensus price target of $100.00.
The stock price for Mustang Bio (NASDAQ: MBIO) is $0.4455 last updated November 11, 2026 at 6:20 PM EST.
There are no upcoming dividends for Mustang Bio.
Mustang Bio does not have any upcoming earnings scheduled.
There is no upcoming split for Mustang Bio.
Mustang Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an...